Literature DB >> 7814633

Tat-independent replication of human immunodeficiency viruses.

L Luznik1, G Kraus, J Guatelli, D Richman, F Wong-Staal.   

Abstract

The replication of human immunodeficiency retroviruses involves a complex series of events that is regulated at both transcriptional and posttranscriptional levels. The tat gene product is a potent trans-activator of viral transcription and therefore an attractive target for the development of antiviral drugs. Tat-defective HIV-1 proviral DNA clones have been shown previously to be replication defective. In this study, we report that tat-defective HIV-1 and HIV-2 viral DNA transfected into U937 cells can direct efficient viral replication in the presence of transcriptional stimulators such as TNF-alpha and PMA. In MT-4 cells, tat-defective HIV-1 can replicate without any stimulation. The viruses recovered from MT-4 cells remained tat defective defined by their inability to infect T cell lines (e.g., Molt 4/8) although replication could be rescued with cytokines. Limited replication was observed in primary mononuclear cells. Furthermore, we showed that Ro 24-7429, a potent tat antagonist and antiviral compound, failed to suppress HIV-1 replication in TNF-alpha-stimulated T cells. These results have important implications for targeting tat as a therapeutic strategy for AIDS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814633      PMCID: PMC295435          DOI: 10.1172/JCI117660

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  The trans-activator gene of HTLV-III is essential for virus replication.

Authors:  A G Fisher; M B Feinberg; S F Josephs; M E Harper; L M Marselle; G Reyes; M A Gonda; A Aldovini; C Debouk; R C Gallo
Journal:  Nature       Date:  1986 Mar 27-Apr 2       Impact factor: 49.962

2.  Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor.

Authors:  M R Sadaie; J Rappaport; T Benter; S F Josephs; R Willis; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients.

Authors:  S C Wright; A Jewett; R Mitsuyasu; B Bonavida
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

4.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

5.  Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

Authors:  K A Jones; J T Kadonaga; P A Luciw; R Tjian
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

6.  Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells.

Authors:  F Fazely; B J Dezube; J Allen-Ryan; A B Pardee; R M Ruprecht
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

7.  Improved tissue culture technique for production of poorly replicating human immunodeficiency virus strains.

Authors:  B Asjö; J Albert; F Chiodi; E M Fenyö
Journal:  J Virol Methods       Date:  1988 Mar-Apr       Impact factor: 2.014

8.  Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes.

Authors:  C Parrott; T Seidner; E Duh; J Leonard; T S Theodore; A Buckler-White; M A Martin; A B Rabson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes.

Authors:  D Harrich; J Garcia; R Mitsuyasu; R Gaynor
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.

Authors:  G Poli; P Bressler; A Kinter; E Duh; W C Timmer; A Rabson; J S Justement; S Stanley; A S Fauci
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more
  12 in total

1.  Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin.

Authors:  K Verhoef; M Tijms; B Berkhout
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

Review 2.  Potential implication of residual viremia in patients on effective antiretroviral therapy.

Authors:  Gautam K Sahu
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

3.  TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.

Authors:  Anna Kajaste-Rudnitski; Sara S Marelli; Cinzia Pultrone; Thomas Pertel; Pradeep D Uchil; Nadir Mechti; Walther Mothes; Guido Poli; Jeremy Luban; Elisa Vicenzi
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

4.  Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.

Authors:  J M Jacqué; B Fernández; F Arenzana-Seisdedos; D Thomas; F Baleux; J L Virelizier; F Bachelerie
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats.

Authors:  Y Inoshima; M Kohmoto; Y Ikeda; H Yamada; Y Kawaguchi; K Tomonaga; T Miyazawa; C Kai; T Umemura; T Mikami
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.

Authors:  A Gervaix; D West; L M Leoni; D D Richman; F Wong-Staal; J Corbeil
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  Heat shock induces HIV-1 replication in chronically infected promyelocyte cell line OM10.1.

Authors:  K Hashimoto; M Baba; K Gohnai; M Sato; S Shigeta
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy.

Authors:  Janet Chung; Jane Zhang; Haitang Li; Dominique L Ouellet; David L DiGiusto; John J Rossi
Journal:  Hum Gene Ther       Date:  2012-09-18       Impact factor: 5.695

9.  An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.

Authors:  Celsa A Spina; Jenny Anderson; Nancie M Archin; Alberto Bosque; Jonathan Chan; Marylinda Famiglietti; Warner C Greene; Angela Kashuba; Sharon R Lewin; David M Margolis; Matthew Mau; Debbie Ruelas; Suha Saleh; Kotaro Shirakawa; Robert F Siliciano; Akul Singhania; Paula C Soto; Valeri H Terry; Eric Verdin; Christopher Woelk; Stacey Wooden; Sifei Xing; Vicente Planelles
Journal:  PLoS Pathog       Date:  2013-12-26       Impact factor: 6.823

10.  In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia.

Authors:  Marion Pardons; Linos Vandekerckhove; Basiel Cole; Laurens Lambrechts; Pierre Gantner; Ytse Noppe; Noah Bonine; Wojciech Witkowski; Lennie Chen; Sarah Palmer; James I Mullins; Nicolas Chomont
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.